Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Handbook of Experimental Pharmacology|December 16, 2017
Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid LeukemiaFederico Lussana, Tamara Intermesoli, Paola Stefanoni, et al.American Journal of Hematology|July 10, 2007
Abnormally expanded pro-B hematogones associated with congenital cytomegalovirus infectionTamara Intermesoli, Giovanna Mangili, Anna Salvi, et al.Current Oncology Reports|January 21, 2022
Lymphoblastic Lymphoma: a Concise ReviewTamara Intermesoli, Alessandra Weber, Matteo Leoncin, et al.Annals of Hematology|June 30, 2011
Efficacy of an intensive post-induction chemotherapy regimen for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia, given predominantly in the out-patient settingTamara Intermesoli, Shekhar Krishnan, Finlay MacDougall, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2011
Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumabLuca Bologna, Elisa Gotti, Massimiliano Manganini, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2012
Ofatumumab is more efficient than rituximab in lysing B chronic lymphocytic leukemia cells in whole blood and in combination with chemotherapyLuca Bologna, Elisa Gotti, Fabio Da Roit, et al.Oncotarget|July 13, 2014
Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib responseAlessandra Iurlo, Umberto Gianelli, Alessandro Beghini, et al.Haematologica|January 12, 2005
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 casesNicola Vianelli, Monica Galli, Antonio de Vivo, et al.Cancers|June 13, 2020
Capture-based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular ProbesRoberta Cavagna, Marie L Guinea Montalvo, Manuela Tosi, et al.Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic LeukemiaRenato Bassan, Tamara Intermesoli, Annamaria Scattolin, et al.Pageof 5